Creative Planning’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Creative Planning’s Portfolio VAXX Stock Details VAXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-286,862	Closed	-$206K	–	3206
2024 Q1	$206K	Buy	286,862 +1,773	+0.6%	+$1.28K	﹤0.01%	2547
2023 Q4	$242K	Buy	285,089 +6,443	+2%	+$6.22K	﹤0.01%	2262
2023 Q3	$382K	Sell	278,646 -799	-0.3%	-$1.73K	﹤0.01%	1753
2023 Q2	$704K	Hold	279,445	–	–	﹤0.01%	1332
2023 Q1	$634K	Hold	279,445	–	–	﹤0.01%	1330
2022 Q4	$391K	Sell	279,445 -1,000	-0.4%	-$1.68K	﹤0.01%	1557
2022 Q3	$555K	Buy	280,445 +2,924	+1%	+$6.09K	﹤0.01%	1275
2022 Q2	$436K	Buy	+277,521	New	+$1.05M	﹤0.01%	1392

Other funds holding VAXX

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

CGL

Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Creative Planning's VAXX Position: Q2 2024 in Review

Creative Planning sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 286,862 shares — an estimated $206K sold.

Creative Planning first reported a position in VAXX in Q2 2022 and held it in 8 quarters. The position peaked at $704K in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

Creative Planning reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
Creative Planning sold 286,862 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $206K.
Creative Planning first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2022 and held it in 8 quarters.
Creative Planning's Vaxxinity, Inc. Class A Common Stock position peaked at $704K in Q2 2023.
8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Creative Planning's 13F filing for Q2 2024, filed 15 Aug 2024.